Artia Global Partners LP Quant / Systematic

Location: Miami, FL

CIK: 0001937964 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value: $517M (100.0% shares, 0.0% debt)

Holdings (46)

NVO NOVO-NORDISK A S 19.1%
Value $98.74M Shares 691,743 Est. Cost $113.34 Unrealized
LLY ELI LILLY & CO 16.2%
Value $83.83M Shares 92,593 Est. Cost $527.62 Unrealized +49.9%
ELI LILLY & CO 13.1%
Value $67.9M Shares 75,000 Est. Cost Unrealized
MRK MERCK & CO INC 10.6%
Value $54.78M Shares 442,504 Est. Cost $100.40 Unrealized +21.2%
NOVO-NORDISK A S 8.6%
Value $44.25M Shares 310,000 Est. Cost Unrealized
VKTX VIKING THERAPEUTICS INC 4.6%
Value $24.01M Shares 452,979 Est. Cost $22.97 Unrealized +185.4%
AZN ASTRAZENECA PLC 2.9%
Value $14.88M Shares 190,752 Est. Cost $69.76 Unrealized
INTRA-CELLULAR THERAPIES INC 2.9%
Value $14.83M Shares 216,519 Est. Cost $66.05 Unrealized
VRTX VERTEX PHARMACEUTICALS INC 1.7%
Value $8.859M Shares 18,900 Est. Cost $422.74 Unrealized +2.7%
ALNY ALNYLAM PHARMACEUTICALS INC 1.6%
Value $8.505M Shares 35,000 Est. Cost $157.87 Unrealized 0.0%
VIKING THERAPEUTICS INC 1.5%
Value $7.952M Shares 150,000 Est. Cost Unrealized
INSMED INC 1.4%
Value $7.37M Shares 110,000 Est. Cost Unrealized
AXSM AXSOME THERAPEUTICS INC 1.4%
Value $7.072M Shares 87,848 Est. Cost $73.77 Unrealized +0.4%
ARGX ARGENX SE 1.3%
Value $6.51M Shares 15,138 Est. Cost $387.47 Unrealized
NBIX NEUROCRINE BIOSCIENCES INC 1.2%
Value $6.195M Shares 45,000 Est. Cost $117.13 Unrealized +17.1%
PCVX VAXCYTE INC 1.1%
Value $5.758M Shares 76,255 Est. Cost $56.71 Unrealized +20.0%
PTGX PROTAGONIST THERAPEUTICS INC 0.8%
Value $4.312M Shares 124,440 Est. Cost $25.24 Unrealized +16.0%
DYN DYNE THERAPEUTICS INC 0.8%
Value $4.217M Shares 119,488 Est. Cost $22.62 Unrealized +28.5%
SLNO SOLENO THERAPEUTICS INC 0.7%
Value $3.852M Shares 94,424 Est. Cost $43.62 Unrealized -2.8%
CRNX CRINETICS PHARMACEUTICALS IN 0.7%
Value $3.841M Shares 85,765 Est. Cost $39.13 Unrealized +18.0%
INSM INSMED INC 0.7%
Value $3.58M Shares 53,436 Est. Cost $26.68 Unrealized +45.3%
OCUL OCULAR THERAPEUTIX INC 0.7%
Value $3.42M Shares 500,000 Est. Cost $4.58 Unrealized +34.7%
IONS IONIS PHARMACEUTICALS INC 0.6%
Value $2.978M Shares 62,479 Est. Cost $41.01 Unrealized 0.0%
MERUS N V 0.6%
Value $2.969M Shares 50,171 Est. Cost $45.03 Unrealized
CLDX CELLDEX THERAPEUTICS INC NEW 0.5%
Value $2.787M Shares 75,300 Est. Cost $37.73 Unrealized 0.0%
APGE APOGEE THERAPEUTICS INC 0.4%
Value $2.298M Shares 58,400 Est. Cost $39.68 Unrealized +22.3%
SPRINGWORKS THERAPEUTICS INC 0.4%
Value $2.032M Shares 53,930 Est. Cost $49.22 Unrealized
IDYA IDEAYA BIOSCIENCES INC 0.4%
Value $1.91M Shares 54,392 Est. Cost $42.88 Unrealized -7.6%
VERONA PHARMA PLC 0.4%
Value $1.891M Shares 130,790 Est. Cost $19.88 Unrealized
XENE XENON PHARMACEUTICALS INC 0.3%
Value $1.56M Shares 40,000 Est. Cost $46.00 Unrealized -13.1%
MREO MEREO BIOPHARMA GROUP PLC 0.3%
Value $1.517M Shares 421,359 Est. Cost $3.30 Unrealized
CRL CHARLES RIV LABS INTL INC 0.3%
Value $1.426M Shares 6,905 Est. Cost $226.63 Unrealized -0.0%
KURA KURA ONCOLOGY INC 0.2%
Value $1.177M Shares 57,178 Est. Cost $19.79 Unrealized +3.9%
NAMS NEWAMSTERDAM PHARMA COMPANY 0.2%
Value $1.043M Shares 54,285 Est. Cost $20.30 Unrealized -1.2%
ASND ASCENDIS PHARMA A/S 0.2%
Value $1.015M Shares 7,440 Est. Cost $151.17 Unrealized
SLN SILENCE THERAPEUTICS PLC 0.2%
Value $997K Shares 52,476 Est. Cost $21.60 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 0.2%
Value $991K Shares 48,263 Est. Cost $20.93 Unrealized 0.0%
KROS KEROS THERAPEUTICS INC 0.2%
Value $914K Shares 20,000 Est. Cost $53.73 Unrealized 0.0%
CRBP CORBUS PHARMACEUTICALS HLDGS 0.2%
Value $905K Shares 20,000 Est. Cost $42.06 Unrealized 0.0%
EYPT EYEPOINT PHARMACEUTICALS INC 0.2%
Value $883K Shares 101,500 Est. Cost $12.75 Unrealized +9.5%
ANNX ANNEXON INC 0.1%
Value $723K Shares 147,485 Est. Cost $5.19 Unrealized -0.4%
LRMR LARIMAR THERAPEUTICS INC 0.1%
Value $656K Shares 90,490 Est. Cost $7.74 Unrealized -1.1%
IRON DISC MEDICINE INC 0.1%
Value $606K Shares 13,440 Est. Cost $64.84 Unrealized -47.6%
PLRX PLIANT THERAPEUTICS INC 0.1%
Value $538K Shares 50,000 Est. Cost $23.67 Unrealized -45.5%
MDGL MADRIGAL PHARMACEUTICALS INC 0.1%
Value $436K Shares 1,557 Est. Cost $235.62 Unrealized +1.0%
SRPT SAREPTA THERAPEUTICS INC 0.1%
Value $411K Shares 2,600 Est. Cost $128.46 Unrealized 0.0%